Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $39.66M in the quarter ending June 30, 2026, with 53.25% growth. This brings the company's total for the last twelve months to $136.07M, up 119.40% year-over-year. In the year 2025, Zevra Therapeutics had annual revenue of $106.47M with 350.91% growth. That makes Zevra Therapeutics the 20,343rd largest company in the world by revenue and 3,102nd in the United States.

• Revenue (ttm): $136.07M
• Revenue Growth: +119.40%
• P/S Ratio: 4.16
• Revenue / Employee: $2,230,672
• Employees: 61
• Market Cap: 565.93M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	106.47M	82.86M	350.91%
Dec 31, 2024	23.61M	-3.85M	-14.02%
Dec 31, 2023	27.46M	17.00M	162.58%
Dec 31, 2022	10.46M	-18.19M	-63.50%
Dec 31, 2021	28.65M	15.36M	115.61%
Dec 31, 2020	13.29M	449.00K	3.50%
Dec 31, 2019	12.84M	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error